“To emerge as a leading and exclusive Indian player in the field of tobacco cessation and biopharmaceuticals in with particular focus Nicotine Chewing Gums and Lozenges, offering ethnic flavoured products for tobacco chewers, in addition to smokers, enabling them to quit the habit successfully”

• Creating awareness about our product
• Quality assurance for our products
• Consistent focus on consumer demands
• Positive growth of the NuLife brand

About Us

Ceejay Healthcare Pte Ltd is pharmaceutical company with difference, focused on biopharmaceuticals, phyto-pharmaceuticals and herbal extracts, established by Ceejay Group in joint venture with Nulife Ltd, Jersey through their wholly owned Zenara Pharma Ltd, London, UK

Ceejay launched Nicotine Polacrilex chewing gum USP in India in the year 2003 and thanks to the vertically integrated proprietary technology of NULIFE (Zenara Pharma Ltd, London) exclusive leadership position has been established in India. Currently Ceejay is working closely with NULIFE (Zenara Pharma Ltd) to introduce NICOTINE LOZENGES in India.

For the first time in the world, NULIFE Chewing gums (soon Lozenges) are available for both smokers and tobacco chewers. While smoking cessation version is available in Eucomint flavour, for tobacco chewers ethnic Gutkha flavours are offered.

With the advantage of the fully integrated technology from NULIFE (Zenara Pharma Ltd), Ceejay is able to offer their products at prices closer to cigarettes and chewing tobacco products such as Gutkha, snuff, Naswar etc. Thus India is possibly the only country where tobacco cessation products are available at such prices, just 15-pct of the global retail prices.

Head-quartered in Mumbai (Bombay) the commercial Capitol of India with cGMP manufacturing facilities in Nagpur and Hyderabad.